See the latest Coronavirus Information including testing sites, visitation restrictions, appointments and scheduling, and more.
Adults (18-65), Geriatrics (65+)
Adults (18-65), Geriatrics (65+)
Perelman Center for Advanced Medicine
West Pavilion, 4th Floor
3400 Civic Center Boulevard
Philadelphia, PA 19104
A facility of the Hospital of the University of Pennsylvania
The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
Double-hit B cell lymphomaMYC-altered B cell lymphomaDiffuse large B cell lymphomaAggressive B cell lymphoma
Frosch Zachary A K, Landsburg Daniel J: Molecular Risk Stratification in Aggressive B-Cell Lymphomas. Journal of clinical oncology : official journal of the American Society of Clinical Oncology : JCO1903069,2020.
Landsburg Daniel J, Ayers Emily C, Bond David A, Maddocks Kami J, Karmali Reem, Behdad Amir, Curry Madeira, Wagner-Johnston Nina D, Modi Dipenkumar, Ramchandren Radhakrishnan, Assouline Sarit E, Faramand Rawan, Chavez Julio C, Torka Pallawi, Mier Hicks Angel, Medeiros L Jeffrey, Li Shaoying: Poor outcomes for double-hit lymphoma patients treated with curative-intent second-line immunochemotherapy following failure of intensive front-line immunochemotherapy. British journal of haematology : 2019.
Emily C. Ayers, Shaoying Li, Jeffrey Medeiros, David A. Bond, Kami J. Maddocks, Pallawi Torka, Angel Mier Hicks, Madeira Curry, Nina D. Wagner-Johnston, Reem Karmali, Amir Behdad, Bita Fakhri, Brad S Kahl, Michael C Churnetski, Jonathon B. Cohen, Nishitha Reddy, Dipenkumar Modi, Radhakrishnan Ramchandren, Christina Howlett, Lori A. Leslie, Samuel Cytryn, Catherine Diefenbach, Rawan Faramand, Julio C. Chavez, Adam J Olszewski, Yang Liu, Stefan Klaus Barta, Dhruvika Mukhija, Brian T. Hill, Helen Ma, Jennifer E Amengual, Sunita Nathan, Sarit Assouline, Victor M. Orellana-Noia, Craig A. Portell, Ashwin Chandar, Kevin A. David, Anshu Giri, Brian T. Hess, and Daniel J. Landsburg: Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure. Cancer 126 (2): 293-303,2019.
Landsburg Daniel J, Hughes Mitchell E, Koike Alexa, Bond David, Maddocks Kami J, Guo Ling, Winter Allison M, Hill Brian T, Ondrejka Sarah L, Hsi Eric D, Nasta Sunita D, Svoboda Jakub, Schuster Stephen J, Bogusz Agata M: Outcomes of patients with relapsed/refractory double-expressor B-cell lymphoma treated with ibrutinib monotherapy. Blood advances 3 (2): 132-135,2019.
Landsburg Daniel J, Kahl Brad S: Can We Exploit the Molecular Heterogeneity of Aggressive B Cell Lymphomas Into Effective New Therapies? Clinical lymphoma, myeloma & leukemia 19 (2): 65-67,2018.
Rhodes Joanna, Landsburg Daniel J: Small-Molecule Inhibitors for the Treatment of Diffuse Large B Cell Lymphoma. Current hematologic malignancy reports 13 (5): 356-368,2018.
Landsburg Daniel J: Advancing the management of double hit lymphoma. Oncotarget 8 (45): 78245-78246,2017.
Landsburg Daniel J, Falkiewicz Marissa K, Maly Joseph, Blum Kristie A, Howlett Christina, Feldman Tatyana, Mato Anthony R, Hill Brian T, Li Shaoying, Medeiros L Jeffrey, Torka Pallawi, Hernandez-Ilizaliturri Francisco, Reddy Nishitha M, Singavi Arun, Fenske Timothy S, Chavez Julio C, Kaplan Jason B, Behdad Amir, Petrich Adam M, Bast Martin A, Vose Julie M, Olszewski Adam J, Costa Cristiana, Lansigan Frederick, Gerson James N, Barta Stefan K, Calzada Oscar, Cohen Jonathon B, Lue Jennifer K, Amengual Jennifer E, Rivera Xavier, Persky Daniel O, Peace David J, Nathan Sunita, Cassaday Ryan D: Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 35 (20): JCO2017722157,2017.
Division of Hematology OncologyPerelman Center for Advanced Medicine12th Floor, South PavilionOffice #12-1823400 Civic Center Boulevard
Patient appointments: 800-789-7366